Professional Background Clause Samples

Professional Background. Dr. Yasenik has the following professional affiliations: Ø Registered Clinical Social Worker, College of Alberta Social Workers (CASW) Ø Registered Family Mediator (Alberta Family Mediation Society (AFMS) Ø Registered Parenting Coordinator- Arbitrator (AFMS) Ø Certified Child Psychotherapist and Play Therapist - Supervisor (CACPT-S) Ø Registered Play Therapist Association of Play Therapy – Supervisor (APT-S) Ø Approved Trainer for CACPT and APT (Internationally) Dr. Yasenik is an international trainer in the area of child psychotherapy and play therapy for qualified mental health workers in 7 different countries. She has experience as an expert witness in Family Court and Court of Queen’s Bench. She has worked extensively with Child and Family Services with children “at risk” and is currently involved with the Law Reform group in Alberta. Dr. Yasenik completed research in the area of “Including the Voices of Children in the Legal System” (2013).

Professional Background. ▇▇▇▇▇▇▇▇ ▇▇▇▇ is a Commercial Real Estate Associate Advisor with NCG Commercial Real Estate. ▇▇▇▇▇▇▇▇ specializes in office properties in the San Antonio Market including New Braunfels and surrounding areas, as well as South Central Texas. ▇▇▇▇▇▇▇▇ represents both buyers and sellers in these areas. She also has a background in the automotive and finance industries with several years’ experience in those fields. ▇▇▇▇▇▇▇▇ was born in Austin and raised in New Braunfels, TX (Comal County) and received her Bachelors of Arts from Sweet Briar College, Sweet Briar, VA in 1997. ▇▇▇▇▇▇▇▇ has resided in New Braunfels for over 35 years. ▇▇▇▇▇▇▇▇ is an active member of her church and volunteers with the Comal County Habitat for Humanity.

Professional Background. 7.1 Please describe your current profession: 7.2 Number of years in this profession: 7.3 Please give us a brief summary of your important professional important milestones that you feel are important to this Intensive:

Professional Background. ▇▇. ▇▇▇▇▇▇▇ received the degree of Bachelor of Arts in economics from Manchester Metropolitan University in the United Kingdom. ▇▇. ▇▇▇▇▇▇▇ joined Parent from Biogen Idec (▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇; tel.: ▇▇▇ ▇▇▇ ▇▇▇▇), the principal business of which is the development and delivery of therapies for diseases, where he held global and country leadership positions during his thirteen-year career with the company. Most recently, he was senior vice president of the company's United States commercial organization from 2011 to 2014. From 1998 to 2001, he was at Sanofi in the United Kingdom and held various marketing roles across the company's urology, analgesics and cardiovascular products. He also held sales and marketing positions at Lorex Synthélabo and Wyeth. ▇▇▇▇ ▇▇▇▇▇▇, British Function at Parent. ▇▇▇▇ ▇▇▇▇▇▇ has been CEO of Novartis Pharmaceuticals since 2016 and is a member of the Executive Committee. Professional Background. ▇▇. ▇▇▇▇▇▇ holds a degree in economics from Manchester Metropolitan University in the United Kingdom and a diploma in marketing from the Chartered Institute of Marketing, also in the United Kingdom. ▇▇. ▇▇▇▇▇▇ joined Parent from AstraZeneca, the principal business of which is the development and sales of pharmaceutical products, where he served from 2013 to 2016 as president of AstraZeneca United States and executive vice president of AstraZeneca North America (both located at ▇▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, ▇▇▇▇▇▇▇▇▇▇, ▇▇ ▇▇▇▇▇; tel.: ▇▇▇ ▇▇▇ ▇▇▇▇). From 2011 to 2013, he served as representative director and president of AstraZeneca K.K. (located at ▇ ▇▇▇▇▇▇▇▇, ▇▇▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇-▇▇▇▇; tel.: +▇▇ ▇ ▇▇▇▇ ▇▇▇▇), the Japanese subsidiary of AstraZeneca. He also served as president of AstraZeneca's business in Spain and as vice president and primary care director, United Kingdom. Before AstraZeneca, ▇▇. ▇▇▇▇▇▇ held roles of increasing responsibility at Schering-Plough, including leading biologics global marketing. He began his career in sales and marketing roles at GlaxoSmithKline UK and Sanofi-Synthélabo UK. ▇▇▇▇▇ ▇▇▇▇▇▇, German Function at Parent. ▇▇▇▇▇ ▇▇▇▇▇▇ has been Chief Financial Officer (CFO) since 2013 and is a member of the Executive Committee. ▇▇. ▇▇▇▇▇▇ joined Parent in 2003 and, prior to his current position, served as CFO of the Pharmaceuticals Division. At Parent, he also served as CFO of Pharma Europe and as Head of Business Planning & Analysis and Financial Operations for the Pharmaceuticals Division. ▇▇. ...

Professional Background. ▇▇. ▇▇▇▇ began his career at the American University of Beirut Medical Center in Lebanon and completed his fellowship and residency training at the Massachusetts Eye and Ear Infirmary at Harvard Medical School. His research on matrix metalloproteinases in corneal wound healing and angiogenesis has been funded by the U.S. National Institutes of Health since 1993. ▇▇. ▇▇▇▇ practiced at the ▇▇▇▇▇▇ Eye Institute at the ▇▇▇▇▇ ▇▇▇▇▇▇▇ Hospital School of Medicine, then returned to the Massachusetts Eye and Ear Infirmary as director of cornea and external disease. He became professor of ophthalmology with tenure at Harvard Medical School in 2003. ▇▇. ▇▇▇▇ holds the degree of Executive Master of Business Administration from the University of Chicago Booth School of Business. Ton ▇▇▇▇▇▇▇▇, Dutch Function at Parent. Ton ▇▇▇▇▇▇▇▇ has been a member of the Board of Directors since February 23, 2016. He qualifies as an independent Non-Executive Director and is a member of the Risk Committee. Other Activities. From 2012 to 2017, ▇▇. ▇▇▇▇▇▇▇▇ served as chairman and CEO of the executive board of Dutch multinational AkzoNobel (located at ▇▇▇▇▇▇▇▇▇ ▇▇, ▇▇▇▇ ▇▇ ▇▇▇▇▇▇, the Netherlands; tel.: +▇▇ ▇▇ ▇▇▇ ▇▇▇▇), the principal business of which is the development of paints, performance coatings and special chemicals. Prior to joining AkzoNobel, he spent almost two decades at the Sulzer Corporation in Switzerland, where he was appointed divisional president in 2001 and served as president and CEO from 2007 to 2011. ▇▇. ▇▇▇▇▇▇▇▇'▇ early career was spent in the oil and gas construction industry and included roles at Allseas Engineering in the Netherlands and at ▇▇▇▇ Kvaerner in Singapore. Since 2014, he has been a member of the supervisory board of Voith GmbH (located at St. ▇▇▇▇▇▇▇▇ ▇▇▇▇▇▇ ▇▇, ▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇; tel.: +▇▇ ▇▇ ▇▇▇▇ ▇▇▇▇), the principal business of which is mechanical engineering.

Professional Background. My professional background includes community mental health, emergency services, and outpatient counseling. I have worked at an inpatient crisis stabilization and detox center providing direct client care and individual and group counseling interventions. During my time in emergency services, I worked in the local emergency department, inpatient psychiatric units, correctional facilities, and walk-in behavioral health center providing evaluations for services. I have worked in administrative roles managing referrals and maintaining high levels of utilization of services and supervised up to eight clinical staff at a time. I have provided intensive in home, mental health skill building, outpatient crisis services, and parenting support services for individuals of a variety of ages and mental health needs. In my outpatient practice I work with individuals aged 13 and older who are experiencing anxiety and depression, as well as working to heal from traumatic experiences. My approach to supervision is relationship-oriented with cognitive-behavioral supervision processes. This means that my first priority is to understand your personal qualities as a therapist, increase your awareness and insight of yourself and your techniques, and apply this awareness to the counseling process. I will provide feedback on interventions and techniques and will work to identify and address countertransference and areas of dissonance. I want and encourage your feedback during this process, in order to best understand your needs in supervision. We can use telehealth services for supervision through ▇▇▇▇.▇▇. I will ensure I am in a quiet, private space with no distractions, and expect this of my supervisees as well to maintain a level of confidentiality to supervision. I do not engage in supervision via text message or email but will be available by phone in an emergency as these methods are not guaranteed to be secure and are a direct threat to confidentiality. Phone calls may also not be secure but are more secure than other methods of electronic communication. I follow the laws and regulations of the state of Virginia regulating technology-assisted services. There may be limitations to your license or supervision requirements, and it is your responsibility to review these to determine if telehealth supervision can occur.

Professional Background. ▇▇. ▇▇▇▇▇▇▇ ▇. Harris is co-founder and chief executive officer of eMed and is board-certified in psychiatry with experience as a private practicing physician, public health director and patient advocate. ▇▇. ▇▇▇▇▇▇ ▇s a recognized expert in children’s mental health and childhood trauma, and integrating public health, behavioral health and primary care services. ▇▇. ▇▇▇▇▇▇ ▇egularly consults with public and private organizations on health service delivery and emerging trends in health policy. Since October 2020, ▇▇. ▇▇▇▇▇▇ ▇lso serves as Medical Editor In Chief At Large at Everyday Health Group. She holds a B.A. and M.A. from West Virginia University, as well as a M.D. from West Virginia University School of Medicine.

Professional Background. ▇▇. ▇▇▇▇▇▇ holds a degree in industrial engineering and economics from the University of Karlsruhe in Germany. He joined Parent from Procter & ▇▇▇▇▇▇ (P&G) in the United States, where he was CFO of P&G's global pharmaceutical business. Prior to that, he held finance positions in various categories of P&G's consumer goods business, technical operations and Global Business Services organization. ▇▇▇▇▇▇▇ Thyme ▇▇▇▇▇▇▇, American Function at Parent. ▇▇▇▇▇▇▇ Thyme ▇▇▇▇▇▇▇ was appointed Chief Ethics, Risk and Compliance Officer for Novartis on April 1, 2018. She is a member of the Executive Committee. ▇▇. ▇▇▇▇▇▇▇ most recently served as Chief Ethics and Compliance Officer and Head of Litigation for Novartis. She joined Parent in 2011 as General Counsel, North America, for Sandoz in the United States and later became the Global Head of Legal and General Counsel for Sandoz International GmbH. Professional Background. Prior to Parent, ▇▇. ▇▇▇▇▇▇▇ worked in the U.S. as a partner at ▇▇▇▇▇ ▇▇▇▇▇ LLP from 2010 to 2011, senior vice president and general counsel for Solvay Pharmaceuticals Inc. from 2008 to 2010, and vice president of marketing compliance and associate counsel for ▇▇▇▇ Laboratories/Duramed Pharmaceuticals from 2005 to 2007. Before that, she was a partner at ▇▇▇▇▇▇ & Bird LLP in the U.S., where she focused on False Claims Act litigation and antitrust, pharmaceutical legal and regulatory matters. ▇▇. ▇▇▇▇▇▇▇ holds a juris doctor with honors from the University of North Carolina at Chapel Hill and a bachelor's degree in psychology from the University of Notre Dame (both in the U.S.). She is a member of the board of directors of the SIX Group. ▇▇▇▇▇▇▇ ▇▇▇▇, Ph.D., German Function at Parent. ▇▇▇▇▇▇▇ ▇▇▇▇, Ph.D., has been Global Head of Novartis Technical Operations since April 1, 2017. He is a member of the Executive Committee. Prior to his current appointment, ▇▇. ▇▇▇▇ served for two years as Global Head of Biologics Technical Development and Manufacturing within Novartis Technical Operations. Prior to that, ▇▇. ▇▇▇▇ served for six years as Global Head Technical Research & Development. ▇▇. ▇▇▇▇ joined Parent in 1994 as Head of Laboratory in Research, and over the years has held positions of increasing responsibility within the Pharmaceuticals Development. Professional Background. ▇▇. ▇▇▇▇ holds a doctorate in pharmaceutical technology from the Swiss Federal Institute of Technology (ETH Zurich) in Switzerland, and a master's degree in pharmaceutical sciences fr...

Professional Background. ▇▇. ▇▇▇▇▇▇▇ received his bachelor's degree from Colgate University and the degree of Master of Business Administration from the ▇▇▇▇▇▇▇ School of the University of Pennsylvania. He previously ran ▇▇▇▇▇▇▇ Bay, an alternative asset management firm, and was co-CEO of JPMorgan's investment bank from 2003 to 2010. He joined JPMorgan in 1983 and has held management roles across several market areas and in corporate finance. Additionally, he was a commissioner on the United Kingdom Independent Commission on Banking in 2010 and 2011, and he was appointed a Commander of the Order of the British Empire in 2013. ▇▇▇▇▇▇ ▇▇▇▇▇▇▇▇▇▇, M.D., American Function at Parent. Vasant (Vas) ▇▇▇▇▇▇▇▇▇▇, M.D. has been Chief Executive Officer (CEO) since February 1, 2018. ▇▇. ▇▇▇▇▇▇▇▇▇▇ previously held the position of Global Head of Drug Development and Chief Medical Officer for Parent. In 2017, he became a member of the Board of Trustees of the Novartis Foundation. ▇▇. ▇▇▇▇▇▇▇▇▇▇ joined Parent in 2005 and has held numerous leadership positions in development and commercial functions. From 2014 to 2016, he was Global Head of Development for Novartis Pharmaceuticals, overseeing the entire general medicines pipeline. He previously served as Global Head of the Sandoz Biopharmaceuticals and Oncology Injectables business unit in 2014, overseeing the division's biosimilars pipeline, and as Global Head of Development for Novartis Vaccines from 2012 to 2014. ▇▇. ▇▇▇▇▇▇▇▇▇▇ has also held commercial and strategic roles at Parent, including North America Region Head for Novartis Vaccines, and United States Country President for Novartis Vaccines and Diagnostics.